Article
[Classification of hepatitis C virus into two major groups in serologic activity: correlation with response to interferon].
Nihon rinsho. Japanese journal of clinical medicine - 1 Jul 1994
Matsushima T, Karino Y, Hige S, Toyota J
Abstract excerpt
Genotypes of HCV have been reported to be one of the predictors of response to IFN therapy in patients with chronic hepatitis C. HCV genotypes were determined enzyme-linked immunoblot assay based on group I and II specific recombinant peptides of the NS-4 region (amino acid No. 1676-1670). We exa...
Topics
- Chronic Disease
- Genotype
- Hepacivirus
- Hepatitis C
- Humans
- Immunoblotting
- Interferons
- Treatment Outcome
